Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
5.101M
Cash
2.04M
Avg Qtr Burn
-1.032M
Short % of Float
6.99%
Insider Ownership
21.48%
Institutional Own.
2.41%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
IMC-1 (famciclovir + celecoxib) Details Fibromyalgia, Chronic pain | Phase 3 Initiation | |
Halneuron Details Neuropathic pain, Chemotherapy-induced neuropathic pain | Phase 2b Data readout | |
Phase 2 Initiation |